NOI +17% y-o-y and in-line with ABGSCe (+0.4%) Positive value changes (0.
EcoRub publicerade den 24 oktober 2024 bolagets delårsrapport för det tredje kvartalet år 2024 och v...
Vaisala’s growth was slower than we expected as net sales grew 5% to EUR 136.
SRV's net sales in Q3 amounted to EUR 183.5m, slightly above our estimate of EUR 179.
Vitrolife continues to improve its organic growth, and the company has delivered two quarters with c...
4.7% miss on EBITDA vs cons Consumables and Technology good, still challenges in Genetics Estimates ...
Sales and ARR in line with ABGSCe Limited consensus estimate revisions are likely Strong margin due ...
Fiskars’ Q3 adjusted EBIT of EUR 24.3m came 1% above LSEG Data & Analytics consensus expectations.
Redeye takes a more positive stance on Teneo AI following the Q3 report showing accelerating SaaS AR...
Redeye sees that the Q3 financials were not too far from our estimates (though we were slightly too ...
Redeye comments on Polygiene Group´s third quarter of the year.
Redeye sees another quarter in which BONESUPPORT delivers well on sales (beating our US CERAMENT G s...
Redeye comments on Evolution’s Q3-results which was close to our estimates and the company looks to ...
Redeye comments on SHH´s third quarter of the year.
Sales +4% vs. cons, adj. EBITA +20% vs. cons Minor positive consensus estimate revisions Awaiting im...
